Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage ...
The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback